For just pennies a day, omega-3 supplements can save the U.S. economy significantly in cardiovascular-related healthcare costs.
A new economic report shows that taking specific dietary supplements can provide significant individual and societal healthcare savings by reducing the number of hospitalizations and other costly medical events associated with chronic diseases. This infographic demonstrates the cost savings that can be realized through the utilization of omega-3 dietary supplements among all U.S. adults over the age of 55 with Coronary Heart Disease (CHD).
Courtesy of the Council for Responsible Nutrition Foundation (CRNF; Washington, DC), sourced from Frost & Sullivan’s 2013 report “Smart Prevention-Health Care Cost Savings Resulting from the Targeted Use of Dietary Supplements.”
For more infographics, visit www.supplementforsmartprevention.org
Click image to view larger
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.